Literature DB >> 12364368

Acute septic arthritis.

Mark E Shirtliff1, Jon T Mader.   

Abstract

Acute septic arthritis may develop as a result of hematogenous seeding, direct introduction, or extension from a contiguous focus of infection. The pathogenesis of acute septic arthritis is multifactorial and depends on the interaction of the host immune response and the adherence factors, toxins, and immunoavoidance strategies of the invading pathogen. Neisseria gonorrhoeae and Staphylococcus aureus are used in discussing the host-pathogen interaction in the pathogenesis of acute septic arthritis. While diagnosis rests on isolation of the bacterial species from synovial fluid samples, patient history, clinical presentation, laboratory findings, and imaging studies are also important. Acute nongonococcal septic arthritis is a medical emergency that can lead to significant morbidity and mortality. Therefore, prompt recognition, rapid and aggressive antimicrobial therapy, and surgical treatment are critical to ensuring a good prognosis. Even with prompt diagnosis and treatment, high mortality and morbidity rates still occur. In contrast, gonococcal arthritis is often successfully treated with antimicrobial therapy alone and demonstrates a very low rate of complications and an excellent prognosis for full return of normal joint function. In the case of prosthetic joint infections, the hardware must be eventually removed by a two-stage revision in order to cure the infection.

Entities:  

Mesh:

Year:  2002        PMID: 12364368      PMCID: PMC126863          DOI: 10.1128/CMR.15.4.527-544.2002

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  194 in total

1.  Binding of a Staphylococcus aureus bone pathogen to type I collagen.

Authors:  T B Buxton; J P Rissing; J A Horner; K M Plowman; D F Scott; T J Sprinkle; G K Best
Journal:  Microb Pathog       Date:  1990-06       Impact factor: 3.738

2.  Gene conversion in Neisseria gonorrhoeae: evidence for its role in pilus antigenic variation.

Authors:  Q Y Zhang; D DeRyckere; P Lauer; M Koomey
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

Review 3.  Sexually transmitted arthritis syndromes.

Authors:  A Keat
Journal:  Med Clin North Am       Date:  1990-11       Impact factor: 5.456

Review 4.  Fungal arthritis.

Authors:  M L Cuéllar; L H Silveira; L R Espinoza
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

5.  Synovial fluid tests. What should be ordered?

Authors:  R H Shmerling; T L Delbanco; A N Tosteson; D E Trentham
Journal:  JAMA       Date:  1990 Aug 22-29       Impact factor: 56.272

6.  Staphylococcus aureus alpha-toxin attack on human platelets promotes assembly of the prothrombinase complex.

Authors:  M Arvand; S Bhakdi; B Dahlbäck; K T Preissner
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

Review 7.  Infectious arthritis.

Authors:  J W Smith
Journal:  Infect Dis Clin North Am       Date:  1990-09       Impact factor: 5.982

8.  Immune response to polyglycolic acid implants.

Authors:  S Santavirta; Y T Konttinen; T Saito; M Grönblad; E Partio; P Kemppinen; P Rokkanen
Journal:  J Bone Joint Surg Br       Date:  1990-07

9.  Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study.

Authors:  A Frydén; A Bengtsson; U Foberg; B Svenungsson; B Castor; A Kärnell; R Schvarcz; B Lindblom; E Kihlström
Journal:  BMJ       Date:  1990-12-08

10.  Sonography of hip joint in infective arthritis.

Authors:  V K Shiv; A K Jain; K Taneja; S K Bhargava
Journal:  Can Assoc Radiol J       Date:  1990-04       Impact factor: 2.248

View more
  128 in total

1.  The usefulness of multiplex PCR for the identification of bacteria in joint infection.

Authors:  Hwanjung Kim; Jimyung Kim; Chunhwa Ihm
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 2.  Staphylococcal adaptation to diverse physiologic niches: an overview of transcriptomic and phenotypic changes in different biological environments.

Authors:  Sana S Dastgheyb; Michael Otto
Journal:  Future Microbiol       Date:  2015-11-19       Impact factor: 3.165

3.  [The infected implant. Part 1: bacteriology].

Authors:  U Geipel; M Herrmann
Journal:  Orthopade       Date:  2004-12       Impact factor: 1.087

4.  Septic arthritis associated with systemic sepsis.

Authors:  Sung-Weon Jung; Dong-Hee Kim; Sung-Jin Shin; Byoung-Youl Kang; Yil-Ju Eho; Seong-Wook Yang
Journal:  Int Orthop       Date:  2017-07-17       Impact factor: 3.075

5.  Antimicrobial therapy for bone and joint infections.

Authors:  Saima Aslam; Rabih O Darouiche
Journal:  Curr Infect Dis Rep       Date:  2009-01       Impact factor: 3.725

6.  Dual neutralization of TNFR-2 and MMP-2 regulates the severity of S. aureus induced septic arthritis correlating alteration in the level of interferon gamma and interleukin-10 in terms of TNFR2 blocking.

Authors:  Sahin Sultana; Rajen Dey; Biswadev Bishayi
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

7.  Endocarditis associated with vertebral osteomyelitis and septic arthritis of the axial skeleton.

Authors:  Oscar Murillo; Imma Grau; Joan Gomez-Junyent; Celina Cabrera; Alba Ribera; Fe Tubau; Carmen Peña; Javier Ariza; Roman Pallares
Journal:  Infection       Date:  2018-02-02       Impact factor: 3.553

8.  In vivo efficacy of moxifloxacin compared with cloxacillin and vancomycin in a Staphylococcus aureus rabbit arthritis experimental model.

Authors:  Olivier Grossi; Jocelyne Caillon; Cedric Arvieux; Cedric Jacqueline; Denis Bugnon; Gilles Potel; Antoine Hamel
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

9.  Septic arthritis in the native joint.

Authors:  Meghan B Brennan; Jennifer L Hsu
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

Review 10.  [Septic arthritis and spondylodiscitis : Rare but feared diseases].

Authors:  N Jung; S Vossen
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.